Paper38587293
High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort.
Barritt AS and 8 others. Am J Gastroenterol, 2024. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort. Papers, record 38587293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38587293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Non-alcoholic Fatty Liver Disease | Major topic |
| Humans | |
| Female | |
| Male | |
| Middle Aged | |
| Adult | |
| Terminology as Topic | |
| Liver Cirrhosis | |
| Cohort Studies | |
| Aged | |
| Fatty Liver | |
| United States |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Target RWE | PubMed | PubMed | |||
| UL1 TR001442 | NCATS NIH HHS | United States | UL1TR001442 | PubMed | NIH RePORTER |
| U01 DK061734 | NIDDK NIH HHS | United States | U01DK061734 | PubMed | NIH RePORTER |
| U01 DK130190 | NIDDK NIH HHS | United States | U01DK130190 | PubMed | NIH RePORTER |
| R01 DK106419 | NIDDK NIH HHS | United States | R01DK106419 | PubMed | NIH RePORTER |
| R01 DK121378 | NIDDK NIH HHS | United States | R01DK121378 | PubMed | NIH RePORTER |
| R01 DK124318 | NIDDK NIH HHS | United States | R01DK124318 | PubMed | NIH RePORTER |
| P30 DK120515 | NIDDK NIH HHS | United States | P30DK120515 | PubMed | NIH RePORTER |
| P01 HL147835 | NHLBI NIH HHS | United States | P01HL147835 | PubMed | NIH RePORTER |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42846528 | Low Serum Adiponectin May Identify MASLD as a Comorbidity in Patients with Moderate-to-Severe Psoriasis. | Psoriasis (Auckl) | 2026 | https://conductscience.org/library/papers/42846528 | PubMed |
| 42732142 | What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An umbrella review protocol. | Wellcome Open Res | 2026 | https://conductscience.org/library/papers/42732142 | PubMed |
| 42690133 | Prognostic value of liver histology in steatotic liver disease: a systematic literature review and meta-analysis. | J Comp Eff Res | 2026 | https://conductscience.org/library/papers/42690133 | PubMed |
| 42346825 | Comparative Post-Transplant Outcomes in Alcohol-Related Liver Disease and Non-Alcohol Steatohepatitis: A Multicenter Propensity-Matched Study. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42346825 | PubMed |
| 42104084 | Diagnosing and defining MASLD in people living with chronic hepatitis B. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/42104084 | PubMed |
| 41614714 | Association Between Oral Health and Metabolic Dysfunction-Associated Steatotic Liver Disease Among US Adults. | Clin Transl Gastroenterol | 2026 | https://conductscience.org/library/papers/41614714 | PubMed |
| 41360893 | Comparison of prevalence of fatty liver disease according to the different nomenclatures of NAFLD, MAFLD, and MASLD in a large Iranian Population-based study. | Sci Rep | 2025 | https://conductscience.org/library/papers/41360893 | PubMed |
| 41104541 | Reclassifying pediatric NAFLD using the steatotic liver disease framework: A multicenter retrospective study from the NASH CRN. | Hepatology | 2026 | https://conductscience.org/library/papers/41104541 | PubMed |
| 41066381 | Metabolic comorbidities and post-transplant outcomes in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD): a cohort study from a Brazilian tertiary center. | Arch Endocrinol Metab | 2025 | https://conductscience.org/library/papers/41066381 | PubMed |
| 40775615 | Predictive factors for metabolic syndrome in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). | BMC Gastroenterol | 2025 | https://conductscience.org/library/papers/40775615 | PubMed |
| 40475116 | Revisiting MASLD Nomenclature: Insights from the MENA Region and Its Clinical Relevance. | J Clin Exp Hepatol | 2025 | https://conductscience.org/library/papers/40475116 | PubMed |
| 40371650 | Disease classification, diagnostic challenges, and evolving clinical trial design in MASLD. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40371650 | PubMed |
| 39957372 | Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on "Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C". | Clin Mol Hepatol | 2025 | https://conductscience.org/library/papers/39957372 | PubMed |
| 39739194 | Understanding MASH: An Examination of Progression and Clinical Outcomes by Disease Severity in the TARGET-NASH Database. | Adv Ther | 2025 | https://conductscience.org/library/papers/39739194 | PubMed |
| 39678071 | Statin Therapy is Associated With Lower Risk of Mortality Among Liver Transplant Candidates With Metabolic Dysfunction-associated Steatohepatitis. | J Clin Exp Hepatol | 2025 | https://conductscience.org/library/papers/39678071 | PubMed |
| 39018024 | The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints. | Am J Gastroenterol | 2025 | https://conductscience.org/library/papers/39018024 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38587293
GET https://conductscience.org/api/papers/v1/38587293/authors